Oncolytics Biotech (ONCY) Misses Q2 EPS by 1c
Oncolytics Biotech (NASDAQ: ONCY) reported Q2 EPS of ($0.12), $0.01 worse than the analyst estimate of ($0.11).
For earnings history and earnings-related data on Oncolytics Biotech (ONCY) click here.
Oncolytics Biotech (NASDAQ: ONCY) reported Q2 EPS of ($0.12), $0.01 worse than the analyst estimate of ($0.11).
For earnings history and earnings-related data on Oncolytics Biotech (ONCY) click here.